Rua Bioscience

Rua Bioscience EPS

The Earnings per Share (EPS) of Rua Bioscience (RUA.NZ) as of Nov 3, 2026 is -0.02 NZD. In the previous year, Earnings per Share (EPS) was -0.07 NZD — a change of -75.80% (higher).

EPS

-0.02NZD

YoY

-75.80%

Last updated:

Earnings per Share (EPS) of Rua Bioscience is 2025 -0.02 NZD. Earnings per Share (EPS) of Rua Bioscience was 2024 -0.07 NZD. It decreases by -75.80% higher compared to the previous year.

The Rua Bioscience EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2019
-0.01 NZD
Jan 1, 2020
-0.02 NZD
Jan 1, 2021
-0.03 NZD
Jan 1, 2022
-0.05 NZD
Jan 1, 2023
-0.03 NZD
Jan 1, 2024
-0.07 NZD
Jan 1, 2025
-0.02 NZD
The Rua Bioscience EPS history
YEAREPSYoY
-0.02NZD-75.80%
-0.07NZD+123.61%
-0.03NZD-37.02%
-0.05NZD+46.16%
-0.03NZD+72.61%
-0.02NZD+42.93%
-0.01NZD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Rua Bioscience Stock analysis

What does Rua Bioscience do? Rua Bioscience Ltd develops medical cannabis products through research and development, breeding, cultivation, manufacturing, and distribution. The company focuses on medicinal cannabis for Germany and New Zealand, operating one segment that includes R&D and pharmaceutical sales. Its full research laboratory in Gisborne handles cannabinoid testing, microscopic analysis, moisture analysis, sample preparation, extraction, solvent removal, viscosity measurements, and impurity testing. The company generates revenue from the sale of pharmaceutical products in Germany and New Zealand, targeting healthcare providers and patients seeking medical cannabis treatments. R&D activities support product development and regulatory compliance, while the Gisborne laboratory ensures quality control through comprehensive testing services. Rua Bioscience Ltd's primary customers are healthcare providers and patients in Germany and New Zealand who require medicinal cannabis solutions. The firm's products are distributed through pharmaceutical channels, with the Gisborne laboratory providing essential testing to meet market standards and regulatory requirements. Rua Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rua Bioscience stock

Earnings per Share (EPS) of Rua Bioscience is -0.02 NZD in 2025.

Earnings per Share (EPS) of Rua Bioscience changed from -0.07 NZD to -0.02 NZD, representing a -75.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Rua Bioscience since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Rua Bioscience

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Rua Bioscience